Analytical Data
-
基因名
BPY2IP1
- Application
-
别名
BPY2-interacting Protein 1; BPY2IP1; C19orf5; FLJ10669; MAP-1S; MAP1S; MAP1S light chain
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q66K74
-
表达区间
794-1053aa
-
氨基酸序列
LSDSDPVPLAPGAADSDEDTEGFGVPRHDPLPDPLKVPPPLPDPSSICMVDPEMLPPKTARQTENVSRTRKPLARPNSRAAAPKATPVAAAKTKGLAGGDRASRPLSARSEPSEKGGRAPLSRKSSTPKTATRGPSGSASSRPGVSATPPKSPVYLDLAYLPSGSSAHLVDEEFFQRVRALCYVISGQDQRKEEGMRAVLDALLASKQHWDRDLQVTLIPTFDSVAMHTWYAETHARHQALGITVLGSNSMVSMQDDAFP
-
分子量
31.7kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BPY2IP1, a protein that has garnered attention in recent years, is implicated in various cellular processes and may play a role in the immune response and cellular signaling pathways. This protein is encoded by the BPY2IP1 gene, which is found in humans and other species, highlighting its evolutionary significance. Studies suggest that BPY2IP1 may interact with key proteins involved in the regulation of cellular growth and apoptosis, making it a potential target for therapeutic interventions in diseases such as cancer and autoimmune disorders. The functional understanding of BPY2IP1, however, is still in its nascent stages, necessitating extensive research to elucidate its molecular mechanisms. Recent advancements in recombinant protein technology have facilitated the expression and purification of BPY2IP1, enabling researchers to study its biochemical properties and interactions in vitro and in vivo. Moreover, the exploration of BPY2IP1’s structural characteristics through techniques such as X-ray crystallography or NMR spectroscopy could provide insights into its function and potential as a drug target. Given the increasing interest in the role of immune modulators in disease treatment, BPY2IP1 stands out as a promising candidate for further investigation, potentially leading to novel therapeutic strategies that harness its biological functions. Overall, the study of BPY2IP1 not only contributes to our understanding of fundamental cellular processes but also opens avenues for innovative research in biomedicine.












